Medical application of natural product 6-shogaol in enhancing chemosensitivity of pancreatic cancer on gemcitabine and compound drug composite of natural product 6-shogaol
Patent Information
- Authority / Receiving Office
- CN Β· China
- Current Assignee / Owner
- CHINA PHARM UNIV
- Publication Date
- 2013-08-28
- Estimated Expiration
- Not applicable Β· inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of natural medicines, and discloses a medical application of a natural product 6-shogaol that can enhance the chemosensitivity of pancreatic cancer to gemcitabine and a compound pharmaceutical composition thereof. Background technique
[0002] Pancreatic cancer is a malignant tumor of the digestive tract with hidden clinical manifestations, rapid development, and poor prognosis. Its early diagnosis is difficult and treatment methods are limited, so the mortality rate is high. In western countries, the death rate of pancreatic cancer ranks fourth; in my country, pancreatic cancer is also one of the three major digestive tract malignancies. Traditional treatments for pancreatic cancer mainly include surgery, radiotherapy, and chemotherapy. So far, surgery is still the most effective treatment for pancreatic cancer, but pancreatic cancer lacks obvious symptoms in the early stage, and most cases have lost the chance of r...